APA (7th ed.) Citation

C, L., R, S., V, T., A, M., & T, A. (2026). Migraine Patients Treated With Erenumab and the Risk of Hypertension: A Registry-Based Real-World Study. European journal of neurology, 33(4), e70597. https://doi.org/10.1111/ene.70597

Chicago Style (17th ed.) Citation

C, Lampl, Suliman R, Tischler-Strasser V, MaassenVanDenBrink A, and Alsaadi T. "Migraine Patients Treated With Erenumab and the Risk of Hypertension: A Registry-Based Real-World Study." European Journal of Neurology 33, no. 4 (2026): e70597. https://doi.org/10.1111/ene.70597.

MLA (9th ed.) Citation

C, Lampl, et al. "Migraine Patients Treated With Erenumab and the Risk of Hypertension: A Registry-Based Real-World Study." European Journal of Neurology, vol. 33, no. 4, 2026, p. e70597, https://doi.org/10.1111/ene.70597.